Earnings Summary

Molecular Data Inc’s revenue jumped 36.81% since last year same period to $4062.68Mn in the Q4 2019. On a quarterly growth basis, Molecular Data Inc has generated 0.96% jump in its revenue since last 3-months.

Molecular Data Inc’s net profit jumped 63.79% since last year same period to $-60.33Mn in the Q4 2019. On a quarterly growth basis, Molecular Data Inc has generated -104.14% fall in its net profits since last 3-months.

Molecular Data Inc’s net profit margin jumped 73.53% since last year same period to -1.48% in the Q4 2019. On a quarterly growth basis, Molecular Data Inc has generated -102.2% fall in its net profit margins since last 3-months.

Molecular Data Inc’s earning per share (EPS) estimates for the current quarter stand at 0 - a NaN% jump from last quarter’s estimates.

Molecular Data Inc’s earning per share (EPS) estimates for the current year stand at 0.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Molecular Data Inc’s return on assets (ROA) stands at -0.21.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Molecular Data Inc’s return on equity (ROE) stands at -49.36.